- Home
- RRBI vs PROK Comparison
RRBI vs PROK Comparison
Compare RRBI & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRBI
- PROK
- Stock Information
- Founded
- RRBI 1998
- PROK 2015
- Country
- RRBI United States
- PROK United States
- Employees
- RRBI N/A
- PROK N/A
- Industry
- RRBI Hotels/Resorts
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RRBI Consumer Discretionary
- PROK Health Care
- Exchange
- RRBI Nasdaq
- PROK Nasdaq
- Market Cap
- RRBI 406.6M
- PROK 334.8M
- IPO Year
- RRBI 2019
- PROK N/A
- Fundamental
- Price
- RRBI $64.57
- PROK $2.62
- Analyst Decision
- RRBI Buy
- PROK Buy
- Analyst Count
- RRBI 1
- PROK 5
- Target Price
- RRBI $67.00
- PROK $6.25
- AVG Volume (30 Days)
- RRBI 12.8K
- PROK 2.3M
- Earning Date
- RRBI 10-29-2025
- PROK 11-11-2025
- Dividend Yield
- RRBI 0.74%
- PROK N/A
- EPS Growth
- RRBI 23.60
- PROK N/A
- EPS
- RRBI 5.67
- PROK N/A
- Revenue
- RRBI $115,623,000.00
- PROK $527,000.00
- Revenue This Year
- RRBI $5.20
- PROK $265.05
- Revenue Next Year
- RRBI $17.47
- PROK N/A
- P/E Ratio
- RRBI $11.42
- PROK N/A
- Revenue Growth
- RRBI 10.19
- PROK N/A
- 52 Week Low
- RRBI $46.33
- PROK $0.46
- 52 Week High
- RRBI $66.50
- PROK $7.13
- Technical
- Relative Strength Index (RSI)
- RRBI 52.23
- PROK 53.85
- Support Level
- RRBI $63.91
- PROK $2.12
- Resistance Level
- RRBI $65.69
- PROK $3.05
- Average True Range (ATR)
- RRBI 1.01
- PROK 0.23
- MACD
- RRBI -0.15
- PROK 0.04
- Stochastic Oscillator
- RRBI 25.48
- PROK 53.76
About RRBI Red River Bancshares Inc.
Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.